Professor at the University of Washington, School of Pharmacy, CHOICE Institute

Dr. Sullivan completed pharmacy training at Oregon State University in 1983, obtained a master’s degree at the University of Texas in 1986 and a Doctor of Philosophy in health economics and policy at the University of California, Berkeley in 1992. Dr. Sullivan has authored more than 400 articles, book chapters and reports. In many of these, he assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include health-technology assessment, medical decision-making, and economic evaluation of medical technology, including pharmaceuticals.

He is past president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and past chair of the Academy of Managed Care Pharmacy (AMCP) Executive Committee of the Format for Formulary Submissions, the United States’ evidence-based guidelines for formulary decision-making. He served as a member of the Global Initiative for Asthma (GINA) and Global Initiative for Chronic Obstructive Lung Disease (GOLD), committees creating global evidence-based guidelines for asthma and chronic obstructive pulmonary disease. Dr. Sullivan was a member of the Medicare Evidence Development and Coverage Advisory Committee, a member of the Regence Blue Shield and Premera Blue Cross Pharmacy and Therapeutics Committee, and Chair of the Premera Blue Cross Value Assessment Committee. He was awarded the 2014 Stephen G. Avey Lifetime Achievement Award from AMCP and the 2015 American Pharmacists Association (APhA) Academy of Pharmaceutical Research Sciences (APRS) Research Achievement Award, and was named an Icon of Pharmacy (2019) from Oregon State University.